AI-generated summary
The authors reviewed published studies of low-level laser therapy for breast cancer-related lymphedema and pooled comparisons against non-laser treatment with a meta-analysis. They report that a regimen of three sessions per week at 1.5 to 2 J/cm2, and more than 15 sessions, was associated with better swelling outcomes, and that axillary treatment was associated with better quality of life. The authors state that further rigorous, large-scale studies with long-term follow-up are needed.
- Who or what was studied
- Patients with breast cancer-related lymphedema who had completed cancer treatment
- Limits stated in the abstract
- The authors state that further rigorous, large-scale studies including long-term follow-up are needed to substantiate the regimen.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Energy density (fluence)
- 2 J/cm2
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Meta-analysis, Photobiomodulation, Systematic review, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.